Back to Authors

Boral, Andy

0000-0001-6702-630X

A5048943840 | I4210100156

Mayo Clinic

Blueprint Medicines (United States)

Citations 1

Pralsetinib in Patients with RET Fusion–Positive Non-Small-Cell Lung Cancer: A Plain Language Summary of the ARROW Study

Future Oncology | November 2, 2023 | Volume: 20 | Issue: 6 | Pages: 297-306

10.2217/fon-2023-0155 | PMID 37916501